Personal information

Websites & social links

http://www.pahnkelab.eu
Mendeley profile

Other IDs

ResearcherID: G-1757-2010
Scopus Author ID: 16417489700
SciProfiles: 1692232

Keywords

Alzheimer, ABC transporter

Countries

Germany, Norway, Latvia, Israel

Activities

Collapse all

Employment (9)

Tel Aviv University: Tel Aviv, IL

2022-03 to present | Affi. Professor/Lecturer (Georg Wise Faculty of Life Sciences, Department of Neuroscience)
Employment
Source: Self-asserted source
Jens Pahnke

University of Latvia: Riga, LV

2018-11-12 to present | Lead Researcher/ PI
Employment
Source: Self-asserted source
Jens Pahnke

University of Lübeck: Lübeck, Schleswig-Holstein, DE

2014-12-01 to present | Guest-Researcher/ PI
Employment
Source: Self-asserted source
Jens Pahnke

University of Oslo: Oslo, Oslo, NO

2014-09-28 to present | Professor/ PI
Employment
Source: Self-asserted source
Jens Pahnke

Oslo Universitetssykehus: Oslo, NO

2014-09-28 to present | Head of Neuropathology/ PI
Employment
Source: Self-asserted source
Jens Pahnke

Leibniz-Institut für Pflanzenbiochemie: Halle, Sachsen-Anhalt, DE

2014-12-01 to 2021-06-30 | Guest-Researcher/ PI
Employment
Source: Self-asserted source
Jens Pahnke

University of Magdeburg: Magdeburg, Sachsen-Anhalt, DE

2011-12-01 to 2014-12-31 | Researcher (Department of Neurology)
Employment
Source: Self-asserted source
Jens Pahnke

Deutsches Zentrum für Neurodegenerative Erkrankungen eV: Bonn, Nordrhein-Westfalen, DE

2008-04-01 to 2014-09-30 | Professor/Advisor (Standort Rostock/Greifswald, Magdeburg)
Employment
Source: Self-asserted source
Jens Pahnke

University of Rostock: Rostock, Mecklenburg-Vorpommern, DE

2005-12-01 to 2011-11-30 | Professor (Department of Neurology)
Employment
Source: Self-asserted source
Jens Pahnke

Education and qualifications (5)

EuroCNS: Amsterdam, NL

2007 to present | European Fellow in Neuropathology
Qualification
Source: Self-asserted source
Jens Pahnke

University of Rostock: Rostock, DE

2004-11-01 to present | Dr. rer. nat. (Ph.D.) (Faculty of Natural Sciences and Mathematics)
Qualification
Source: Self-asserted source
Jens Pahnke

University of Greifswald: Greifswald, DE

2000-12-19 to present | Dr. med. (M.D.) (Medical Faculty)
Qualification
Source: Self-asserted source
Jens Pahnke

University of Greifswald: Greifswald, DE

2000-12 to present | Staatsexamen Medicine (Medical Faculty)
Education
Source: Self-asserted source
Jens Pahnke

University of Greifswald: Greifswald, DE

2000-11 to present | Diplom Humanbiologie (Faculty of Natural Sciences and Mathematics)
Education
Source: Self-asserted source
Jens Pahnke

Professional activities (10)

Israel Society for Neuroscience: Tel Aviv, IL

2019 to present
Service
Source: Self-asserted source
Jens Pahnke

Scandinavian Neuropathological Society: Oslo, Scandinavia, NO

2002 to present | President 2016-2019
Membership
Source: Self-asserted source
Jens Pahnke

International Society of Neuropathology: Oxford, GB

2002 to present
Service
Source: Self-asserted source
Jens Pahnke

Federation of European Neuroscience Societies: Brussels, BE

2002 to present
Service
Source: Self-asserted source
Jens Pahnke

EuroCNS: Amsterdam, NL

2002 to present
Service
Source: Self-asserted source
Jens Pahnke

Society of Pharmacology: Riga, LV

2022-09-23 | Oswald Schmiedeberg Prize in Pharmacology
Distinction
Source: Self-asserted source
Jens Pahnke

Scandinavian Neuropathological Society: Oslo, NO

2017-01-01 to 2019-09-30 | President
Invited position
Source: Self-asserted source
Jens Pahnke

Neurowissenschaftliche Gesellschaft: Berlin, Berlin, DE

2005 to 2009
Service
Source: Self-asserted source
Jens Pahnke

Alzheimer Forschung Initiative: Düsseldorf, DE

2008 | AFI Research Prize
Distinction
Source: Self-asserted source
Jens Pahnke

Deutsche Gesellschaft für Neuropathologie und Neuroanatomie: Magdeburg, DE

1998 to 2008
Service
Source: Self-asserted source
Jens Pahnke

Funding (19)

ABCMS: The role and function of ABC transporters in autoimmune demyelinating disease of the CNS

2022 to 2026 | Grant
Helse Sør-Øst RHF (Oslo, NO)
GRANT_NUMBER:

2022046
Source: Self-asserted source
Jens Pahnke

TARIMAD: Targeted and Improved Alzheimer’s Disease Drug Development

2021-05 to 2024-04 | Grant
Technology Agency of the Czech Republic (Prague, CZ)
Part of GRANT_NUMBER:

TO100078
Source: Self-asserted source
Jens Pahnke

JPND PETABC: PET analyses of ABC transporter function for diagnostics and stratification of dementia patients

2021-01 to 2024-12 | Grant
Norges Forskningsråd (Lysaker, NO)
GRANT_NUMBER: 327571
Source: Self-asserted source
Jens Pahnke

National network of Advanced Proteomics Infrastructure (NAPI) in Norway

2020 to 2025 | Grant
Norges Forskningsråd (Oslo, Oslo, NO)
Part of GRANT_NUMBER:

295910
Source: Self-asserted source
Jens Pahnke

ABCA1P: S1P and ABC transporters – synergistic treatment targets for Alzheimer´s disease?

2019-12 to 2022-12 | Grant
Helse Sør-Øst RHF (Oslo, Oslo, NO)
GRANT_NUMBER:

2019055
Source: Self-asserted source
Jens Pahnke

ABCHD: The Importance Of ABC Transporters For The Pathogenesis And Treatment Of Huntington’s Disease

2019-12 to 2022-12 | Grant
Helse Sør-Øst RHF (Oslo, Oslo, NO)
GRANT_NUMBER:

2019054
Source: Self-asserted source
Jens Pahnke

Establishment of comprehensive molecular diagnostics for brain tumours in kids in Norway

2019 to 2022 | Grant
Barnekreftforeningen Norge (Oslo, Oslo, NO)
GRANT_NUMBER:

190008
Source: Self-asserted source
Jens Pahnke

Beta-amiloīda peptīda īso analogu potenciāls Alzheimera slimības ārstēšan

2018 to 2021 | Grant
Latvijas Zinātnes Padome (Riga, Riga, LV)
GRANT_NUMBER: lzp-2018/1-0275
Source: Self-asserted source
Jens Pahnke

Evaluation of phytopharmaca for the prevention and therapy of dementias and age-related cognitive dysfunctions

2018 to 2021 | Grant
Ministerium für Wissenschaft und Wirtschaft, Land Sachsen-Anhalt (Magdeburg, Sachsen-Anhalt, DE)
GRANT_NUMBER:

ZS/2016/05/78617
Source: Self-asserted source
Jens Pahnke

JPND PROP-AD: Propagation behaviour of peripheral amyloid-β towards brain structures: effects of the blood-brain barrier

2016-01-01 to 2021-02-31 | Grant
The Research Council of Norway (Oslo, Oslo, NO)
GRANT_NUMBER:

260786
Source: Self-asserted source
Jens Pahnke

FRIMEDBIO: The role of the blood-brain barrier in Alzheimer’s disease function

2016-01-01 to 2021-01-31 | Grant
The Research Council of Norway (Oslo, NO)
GRANT_NUMBER:

251290
Source: Self-asserted source
Jens Pahnke

ABC-AD: ABC transporters as early diagnostics and treatment marker for neurodegenerative dementias – towards a personalised medicine in dementia

2016-01-01 to 2018-12-31 | Grant
Southern and Eastern Norway Regional Health Authority (Hamar, NO)
URL: https://app.dimensions.ai/details/grant/grant.9422294
GRANT_NUMBER: 2016062
Source: Self-asserted source
Jens Pahnke via DimensionsWizard

Regulatory mechanisms of P-glycoprotein in human brain endothelial cells and novel in vivo approaches for the translation of in vitro findings

2015-01-01 to present | Grant
German Research Foundation (Bonn, DE)
GRANT_NUMBER: 283795191
Source: Self-asserted source
Jens Pahnke

The role of the blood-brain barrier in Alzheimer s disease: Interaction of LRP1 and ABC transporter function

2015-01-01 to 2019-01 | Grant
German Research Foundation (Bonn, DE)
GRANT_NUMBER: 263024513
Source: Self-asserted source
Jens Pahnke

JPND NeuroGEM: Identification of genes that modulate the severity of neurodegenerative diseases

2015-01-01 to 2018-12-31 | Grant
The Research Council of Norway (Oslo, NO)
GRANT_NUMBER:

247179
Source: Self-asserted source
Jens Pahnke

TransportDEMENTIA I

2015-01-01 to 2017-12-31 | Grant
The Research Council of Norway (Oslo, NO)
GRANT_NUMBER:

248772
Source: Self-asserted source
Jens Pahnke

PET imaging to assess blood-brain barrier function in alzheimers disease

2014-01-01 to 2018-12 | Grant
German Research Foundation (Bonn, DE)
GRANT_NUMBER: 252102222
Source: Self-asserted source
Jens Pahnke

Alzheimer, Depression and Epilepsy: Common Pathomechanisms and Therapies EU-H2020 #667923-1

2014-01-01 to 2016-12-31 | Grant
The Research Council of Norway (Oslo, NO)
GRANT_NUMBER: 246392
Source: Self-asserted source
Jens Pahnke

The role of the hydrophobic domain of PrP in the generation of ataxia and loss of granular cells of the Shmerling phenotype

2003-01-01 to 2005-12-31 | Grant
German Research Foundation (Bonn, DE)
GRANT_NUMBER: 5419573
Source: Self-asserted source
Jens Pahnke

Peer review (12 reviews for 7 publications/grants)

Review activity for Acta neuropathologica. (4)
Review activity for Acta neuropathologica. (2)
Review activity for Alzheimer's & dementia : (1)
Review activity for BMC biology. (1)
Review activity for Journal of neuroinflammation (2)
Review activity for Molecular neurobiology. (1)
Review activity for Molecular neurobiology. (1)
How many people are using ORCID?